We are monitoring the impact of COVID-19 on APAC TAVR Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Transcatheter Aortic Valve Replacement Market Research Report – Segmented By Surgery Method, Valve Frame Material, Valve Size, Valve Leaflets Material, End Users & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Analysis on Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 318
Pages: 140

APAC TAVR Market Size (2022 to 2027)

The size of the Asia Pacific Transcatheter Aortic Valve Replacement Market is estimated to be worth USD 1.30 billion by 2027 from USD 0.50 billion in 2022, growing at a CAGR of 21.20% between 2022 to 2027.

The APAC Transcatheter aortic valve replacement (TAVR) market is expected to be driven by growth factors such as the increasing prevalence of cardiovascular disorders such as heart failure, congestive heart failure, mitral regurgitation coronary artery disease, severe aortic stenosis, and hypertension. Cardiovascular disease causes the aortic valve to malfunction, fueling the demand for an effective valve replacement procedure. In addition, the elderly population is prone to cardiovascular diseases and vascular complications arising from other chronic diseases. For example, about 5% of the world's population is over 65 and at risk of developing heart valve disease. India's senior population aged above 60 is expected to reach 195 million in 2031 from over 139 million by the end of 2022, an increase of 42% has been recorded over the past decade, according to the National Statistics Office of India report.

Factors such as the increasing obese population, higher risk in diabetic patients, and growing inoperable aortic stenosis are other factors driving the APAC TAVR market. Furthermore, increasing technological advancements and increased demand for minimally invasive catheter-based procedures over conventional open-heart therapies and patients opting for effective and efficient treatment with rapid recovery are driving the market growth. In addition, TAVR in the older population as the open-heart procedure is too risky for them, and the next best alternative is to undergo TAVR.

However, factors such as the high price of TAVR procedures and the limited adoption of the TAVR systems in the APAC population are limiting the growth of the studied market. For now, there are around 257 centers where TAVR is performed in Asia. In addition, the low adoption can be attributed to the high-grade technology required to perform such surgery, which needs a team including skilled interventionists, cardiac-thoracic surgeons, radiologists, and echocardiographs. These factors collectively are limiting the market growth rate in most Asian countries.

In India, the TAVR procedure is carried out at around 30 centers. This is well below the total number of cardiac surgeries needed to be formed in the region. There is a lack of availability of skilled doctors, and poor medical facilities, complex approval systems by regulatory bodies, and the lack of specialized training programs.

This research report on the Asia Pacific TAVR Market has been segmented and sub-segmented into the following categories:

By Surgery Method:

  • Transfemoral Implantation
  • Transapical Implantation
  • Transaortic Implantation
  • Transvaal Implantation                  

By Valve Material:

  • Nitinol
  • Stainless Steel
  • Cobalt-Chromium              

By Valve Size:

  • 14mm to 18 mm
  • 18mm to 22 mm
  • 22mm to 29mm                    

By Valve Leaflets Material:

  • Bovine Heart Tissue
  • Cow Heart Tissue
  • Other Valve Leaflets Material                       

By End Users:

  • Hospitals
  • Ambulatory Surgical Centres
  • Cardiac Catheterization Laboratories     

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

During the forecast period, the APAC TAVR market is expected to be dominated by Japan. This regional market is estimated to exceed over $ 452 million by 2027, due to an increasing prevalence of aortic stenosis in the elderly, according to a report by global data. During the year 2020, Japan accounted for over60% of the TAVR procedures in the APAC region. Factors such as a large elderly patient base, preference for minimally invasive procedures, increased awareness and training of physicians, and advanced devices are driving the Japan TAVR market. Over 43.5 million of the Japanese population are 60 years of age or older. Although TAVR procedures are primarily performed in the 75 and older age group in Japan, the number is expected to go over 21% over the next five years, while currently, less than 11% of patients treated with TAVR are under 75 years of age. In the elderly population, healthcare professionals prefer TAVR to surgical aortic valve replacement for aortic stenosis because of short hospital stay, speedy recovery, low risk of exposure to infections and complications.

India is the fastest-growing country in the APAC TAVR market and is expected to grow at a CAGR of 29.9% during the projected period 2022 to 2027.  Factors such as increased healthcare spending, application of TAVR systems across the region, large patient base, improving healthcare facilities in the Indian TAVR market are expected to provide several opportunities for growth for the market during the forecast period.

KEY MARKET PLAYERS:

Companies playing a promising role in the Asia Pacific Transcatheter Aortic Valve Replacement (TAVR) Market profiled in this report are Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India) and Braile Biomedica (Brazil).

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Surgery Method                                       

                                5.2.1 Introduction                           

                                5.2.2 Transfemoral Implantation                              

                                5.2.3 Transapical Implantation                   

                                5.2.4 Transaortic Implantation                   

                                5.2.5 Transcaval Implantation                    

                5.3 Valve Material                                           

                                5.3.1 Introduction                           

                                5.3.2 Nitinol                       

                                5.3.3 Stainless Steel                       

                                5.3.4 Cobalt-Chromium                

                5.4 Valve Size                                    

                                5.4.1 Introduction                           

                                5.4.2 14mm to 18 mm                    

                                5.4.3 18mm to 22 mm                    

                                5.4.4 22mm to 29mm                     

                5.5 Valve Leaflets Material                                          

                                5.5.1 Introduction                           

                                5.5.2 Bovine Heart Tissue                            

                                5.5.3 Cow Heart Tissue                 

                                5.5.4 Other Valve Leaflets Material                         

                5.6 End Users                                    

                                5.6.1 Introduction                           

                                5.6.2 Hospitals                  

                                5.6.3 Ambulatory Surgical Centres                           

                                5.6.4 Cardiac Catheterization Laboratories                           

6. Geographical Analysis                                                              

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 Australia                   

                                6.3.6 Soth Korea                              

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Edwards Lifesciences Corporation (U.S.)                                       

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Medtronic, Inc. (Ireland)                                      

                8.3 Boston Scientific Corporation (U.S.)                                 

                8.4 Abbott Laboratories (U.S.)                                   

                8.5 St. Jude Medical Inc. (U.S.)                                  

                8.6 JenaValve Technology, Inc. (Germany)                                          

                8.7 Symetis SA (Switzerland)                                      

                8.8 Direct Flow Medical, Inc. (U.S.)                                          

                8.9 Sorin Group (Italy)                                   

                8.10 Meril Life Sciences India Pvt Ltd (India)                                        

                8.11 Braile Biomedica (Brazil)                                     

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

 

  1. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  2. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  3. Asia-Pacific Transfemoral Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  4. Asia-Pacific Transapical Implantation Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  5. Asia-Pacific Transaortic Implantation Market, By Region, From 2022 - 2027 (USD Billion)
  6. Asia-Pacific Transcaval Implantation Market, By Region, From 2022 - 2027 (USD Billion)
  7. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  8. Asia-Pacific Nitinol Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  9. Asia-Pacific Stainless Steel Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  10. Asia-Pacific Cobalt-Chromium Transcatheter Aortic Valve Frame Material Market, By Region, From 2022 - 2027 (USD Billion)
  11. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  12. Asia-Pacific 14mm to 18mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  13. Asia-Pacific 18mm to 22mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  14. Asia-Pacific 22mm to 29mm Transcatheter Aortic Valve Size Market, By Region, From 2022 - 2027 (USD Billion)
  15. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  16. Asia-Pacific Bovine Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  17. Asia-Pacific Cow Heart Tissue Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  18. Asia-Pacific Other Transcatheter Aortic Valve Leaflets Material Market, By Region, From 2022 - 2027 (USD Billion)
  19. Asia-Pacific Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  20. Asia-Pacific Hospitals Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  21. Asia-Pacific Ambulatory Surgical Centres Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  22. Asia-Pacific Cardiac Catheterization Laboratories Transcatheter Aortic Valve Replacement Market, By Region, From 2022 - 2027 (USD Billion)
  23. China Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  24. China Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  25. China Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  26. China Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  27. China Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  28. India Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  29. India Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  30. India Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  31. India Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  32. India Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  33. Japan Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  34. Japan Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  35. Japan Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  36. Japan Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  37. Japan Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  38. South Korea Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  39. South Korea Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  40. South Korea Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  41. South Korea Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  42. South Korea Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)
  43. Australia Transcatheter Aortic Valve Replacement Market, By Surgery Method, From 2022 - 2027 (USD Billion)
  44. Australia Transcatheter Aortic Valve Replacement Market, By Valve Frame Material, From 2022 - 2027 (USD Billion)
  45. Australia Transcatheter Aortic Valve Replacement Market, By Valve Size, From 2022 - 2027 (USD Billion)
  46. Australia Transcatheter Aortic Valve Replacement Market, By Valve Leaflets Material, From 2022 - 2027 (USD Billion)
  47. Australia Transcatheter Aortic Valve Replacement Market, By End Users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample